Cargando cotizaciones...
Previsión
El precio objetivo medio de los analistas es de 32,62€ (+29.554,55%). La mediana es de 32,62€ (+29.554,55%).
| Comprar |
4 |
| Mantener |
1 |
| Vender |
0 |
Noticias Ir al feed de noticias
BiomX buys 10% of Motomea and secures exclusive drone test license
BiomX acquires a 10 percent stake in M.E.A. Testing Systems Ltd. and Mea Motomova India for US$50,000 and obtains an exclusive license to develop and distribute testing solutions for drones. Motomea will issue 1,300,000 restricted shares to the majority holder; the transaction is subject to regulatory and NYSE American approval. BiomX received an option to acquire a controlling majority, with the purchase price to be set based on two times net revenue in 2027 and four times EBITDA in 2028 (multiplied by 90%), payable in shares and cash. Motomea has supplied patented test systems for electric motors for over 25 years, serving aerospace, automotive, industrial, energy and transport sectors; BiomX views this as a complement to its threat-detection and defense activities with expansion potential on the Indian subcontinent. » Más en de.investing.com
BiomX extends payment deadline for Zorronet takeover and issues shares
BiomX extends the maturity of a promissory note of $1.25 million related to the Zorronet acquisition to November 1, 2026, and agrees an initial repayment of $250,000 followed by four monthly installments of $250,000 each. As consideration and to settle accrued interest, BiomX will issue 800,000 restricted common shares to Water.IO; the issuance is subject to customary approvals. The company warns of risks, including possible non‑approval of the share issuance on the NYSE American, insufficient funds for remaining payments, compliance with listing standards, and a going‑concern notice. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | jun 2026 | |
|---|---|---|
| Ingresos | 290,90k | - |
| Beneficio bruto | 84,99k | 134,31% |
| Beneficio neto | −3,31M | 35,47% |
| EBITDA | −3,34M | 31,02% |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 1,18M€ |
Número de acciones | 10,15M |
Máximo/mínimo de 52 semanas | 10,55€ - 0,10€ |
| Dividendos | No |
Beta | 1,37 |
Ratio P/E | −0,01 |
Ratio PEG | 0,00 |
Ratio P/B | 0,13 |
Ratio P/S | 4,13 |
Perfil de la empresa
| Nombre | BIOMX INC. NEW |
| CEO | Michael Oster |
| Empleados | 20 |
Descubrir activos
Los accionistas de BIOMX INC. NEW también invierten en los siguientes activos



